María de los Llanos Gil

Statistics

Publications

Citations

404

H-Index

Active since

2015

Affiliations

Institut Català d'Oncologia(Current)

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Hospital General Universitario Gregorio Marañón

USP Institut Universitari Dexeus

Instituto Oncológico Dr. Rosell

María de los Llanos Gil is an author at Institut Català d'Oncologia specializing in oncology, non-small cell lung cancer therapy, and molecular oncology.

Publications per year

2015–2018

Publications

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Niki Karachaliou, María González‐Cao, Guillermo Crespo et al. · Therapeutic Advances in Medical Oncology · 2018 · 274 citations · Full text

Medicine, Immunology, Oncology +17

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)

Carles Codony, Jordi Codony‐Servat, Niki Karachaliou et al. · Oncotarget · 2017 · 49 citations · Full text

Life Sciences, Molecular Biology, Oncology +10

The epidermal growth factor receptor (EGRF) in lung cancer

Enric Carcereny, Teresa Morán, Laia Capdevila et al. · Translational Respiratory Medicine · 2015 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +17

Outcome prognostic factors in inoperable malignant bowel obstruction

Margarita Romeo, María de los Llanos Gil, José Luis Cuadra‐Urteaga et al. · Supportive Care in Cancer · 2016 · 24 citations

Medicine, Oncology, Surgery +13

Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients.

Niki Karachaliou, Guillermo Crespo, Erika Aldeguer et al. · Journal of Clinical Oncology · 2017 · 13 citations

Life Sciences, Immunology, Oncology +17

1–5 of 5